1LB0E')$*Y5EYP::>KG[_>G(FP;QJ.&(*_-I=E07,AA$)VU
SYSTEM PROCESSING...
1LB0E')$*Y5EYP::>KG[_>G(FP;QJ.&(*_-I=E07,AA$)VU
SYSTEM PROCESSING...
Posted: 2025-08-11 19:17:23 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-08-11 19:18:00 UTC
Verified By
Rollup News
A targeted brain cell transplant replaces diseased microglia with healthy donor cells, offering hope for treating Tay-Sachs and Sandhoff diseases. In mouse models, this method successfully replaced over 85% of microglia, restoring enzyme production, clearing toxic buildup, improving motor skills, and doubling lifespan. The approach avoids toxic full-body preconditioning and works with non-genetically matched donors, potentially making it faster and more accessible. Researchers believe it could be adapted for neurodegenerative diseases like Alzheimer’s or Parkinson’s.
Microglia transplant restores enzyme production.
Motor skills improved and lifespan doubled in mice.
Localized treatment avoids toxic preconditioning.
Non-genetically matched donors can be used.
Potential application for Alzheimer’s and Parkinson’s.
Treating Tay-Sachs and Sandhoff diseases.
Avoiding toxic full-body preconditioning.
Making the therapy faster and more accessible.